|
LAB | Standard Biotools Inc. |
|
|
LAB | Standard Biotools Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 2.86 |
| Leverage | 13.91% |
| Market Cap | $ 188.6m |
| PE | 2.23 |
| Dividend Yield | 0.00% |
| Profit | $ 84.7m |
| Margin | 158.97% |
None